Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 42 filings·Updated 28 Sept 2026
Showing 10 of 42 filings.
28 Sept 20261 filing
Company UpdateGeneral

Vivimed Labs Limited Pre-Facto: 8th CoC meeting under CIRP scheduled for September 29, 2026

CoC meeting details

  • 8th CoC meeting under CIRP scheduled for September 29, 2026 via audio-visual means.
  • Pre-Facto intimation of meeting under CIRP with NCLT order dated 15 April 2026.
  • Narayana Swamy acting as Interim Resolution Professional, functioning as RP under IBC.
  • IBBI registration: IBBI/IPA-002/IP-N01078/2020-2021/13427; AFA valid to 30 June 2027.
  • Stock exchanges: NSE symbol VIVIMEDLAB; BSE code 532660.
Filed 11:11View Source
26 Sept 20262 filings
Company UpdateIntimation of meeting of Committee of Creditors

intimation of meeting of committee of creditors

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 20:38View Source
Company UpdateGeneral

Vivimed Labs CoC approves ROC extension for AGM 2025-26 by three months

CoC extends AGM timeline

  • CoC approved filing with ROC Bangalore to extend AGM for FY 2025-26 by three months.
  • Decision was taken by Resolution by Circulation on 25 September 2026.
Filed 14:41View Source
23 Sept 20262 filings
Insider Trading / SASTClosure of Trading Window

Vivimed Labs Limited trading window closed from 01.10.2026 until 48 hours after the declaration of the financial results for the quarter and half year ended September 30, 2026

Vivimed Labs Limited trading window closed from 01.10.2026 until 48 hours after the declaration of the financial results for the quarter and half year ended September 30, 2026

Filed 16:44View Source
Insider Trading / SASTClosure of Trading Window

Vivimed Labs Ltd - Trading Window Closure from 01.10.2026 till 48 hours after the declaration of the Financial Results for the quarter & half year ended September 30, 2026, which becomes generally available information.

Vivimed Labs Ltd - Trading Window Closure from 01.10.2026 till 48 hours after the declaration of the Financial Results for the quarter & half year ended September 30, 2026, which becomes generally available information.

Filed 16:24View Source
8 Sept 20262 filings
Company UpdateCorporate Insolvency Resolution Process

Vivimed Labs to hold 7th CoC meeting under CIRP on 10 September 2026 via audio-visual means

CoC meeting details

  • 7th CoC meeting for Vivimed Labs Limited under CIRP scheduled on 10 September 2026.
  • Meeting will be held via Audio-Visual Means as per IBC regulations.
  • IRP: T Narayana Swamy, functioning as RP under Section 16(5) of IBC.
  • NCLT order dated 15 April 2026 initiated CIRP.
Filed 16:36View Source
Company UpdateIntimation of meeting of Committee of Creditors

Committee of Creditors meeting on 10th September 2026

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 16:31View Source
17 Aug 20262 filings
Company UpdateCorporate Insolvency Resolution Process

Vivimed Labs' 6th CoC meeting under CIRP scheduled for Aug 18, 2026

Upcoming CoC meeting

  • Sixth CoC meeting for Vivimed Labs under CIRP on 18 Aug 2026 via audio-visual means.
  • Pre-Facto intimation under CIRP Regulations for the upcoming meeting.
  • Previous meetings: Third on 18-06-2026; Fourth on 04-07-2026; Fifth on 20-07-2026.
  • Notice date: 17 Aug 2026.
  • Interim Resolution Professional: Narayana Swamy.
Filed 16:56View Source
Company UpdateIntimation of meeting of Committee of Creditors

6th COC meeting on 18th August 2026

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 16:40View Source
31 Jul 20261 filing
Company UpdateClarification - Financial Results

The Exchange has sought clarification from Vivimed Labs Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 15:10View Source
Showing 10 of 42 filings